- Financials
BioMar welcomes more than 10,800 new owners as trading begins on Nasdaq Copenhagen
Last week, BioMar officially began trading on Nasdaq Copenhagen, marking a significant milestone in the company's history and welcoming more than…
Today, BioMar released its first quarterly report as a publicly listed company. Against a backdrop of geopolitical uncertainty and raw material supply challenges, the company reports volume growth of 5% compared with the year-to-date period last year.
While the feed business continues to perform strongly, the overall first-half results were partly impacted, as expected and planned, by transformation costs related to the strategic development of the technology business towards more direct sales and recurring revenue. In parallel, the recently completed IPO implied higher cost during the period.
“I am proud to see how our business continues to perform, delivering a strong ROIC of 23.2%. With a solid Q2, we have taken an important step into the high season, where our ability to formulate based on nutrients rather than specific raw materials will be put to the test. There is no longer any doubt that prices of marine raw materials will reach record-high levels, reinforcing the relevance of our advanced formulation capabilities.”
Over recent years, we have further strengthened our commercial excellence platform and enhanced our flexibility in raw material substitution. This enables us to continue delivering robust performance across our feed segments, with volume and earnings growth, while helping to mitigate the impact of market turbulence for our customers”, explains Carlos Diaz, CEO, BioMar Group.
The volume growth has mainly been driven by the shrimp segment, while the salmon and selected species segments have been the main drivers of increased earnings due to changes in product mix and with impact from better capacity utilisation and commercial excellence initiatives.
“It is encouraging to see the continued progress in transforming our aquaculture technology solutions business model into a structure based on recurring revenue and reduced dependence on distributors, while also investing to strengthen our future R&D capabilities. At the same time, we are well underway with expanding capacity to support organic growth in the feed business in Ecuador and China. In many ways, this year represents a transition towards further growth, and I remain confident that we will once again deliver strong results while navigating a turbulent business environment”, explains Carlos Diaz and continues:
“Based on our forecasts from the markets, we predicted that favourable biological farming conditions and our proven ability to navigate volatility in the raw material market will create a strong momentum for the business in the second half of the year. Hence, we have decided to upgrade the guidance for both volumes, revenue and EBIT for the year”, concludes Carlos Diaz.
Forward-looking statements
This press release contains forward-looking statements, which are based on current expectations, projections and assumptions about future events. Forward-looking statements are statements (other than statements of historical fact) relating to future events and BioMar’s anticipated or planned financial and operational performance. The words “may”, “will”, “should”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “predict”, “intend” or variations of these words, including negatives thereof, as well as other statements regarding matters that are not historical facts or regarding future events or prospects, constitute forward-looking statements. BioMar has based these forward-looking statements on its current views with respect to future events and financial performance. These views involve a number of known or unknown risks, uncertainties and assumptions, which could cause actual results to differ materially from those predicted in the forward-looking statements and from the past performance of BioMar. Although BioMar believes that the estimates and projections reflected in the forward-looking statements are reasonable, they may prove materially incorrect, and actual results may materially differ, e.g., as the result of risks related to the industry in general or BioMar in particular, including those described in BioMar’s Annual Report 2025 and other information made available by BioMar. As a result, you should not and may not rely on these forward looking statements as a prediction of actual results. Forward-looking statements speak as of the date of this press release and no one undertakes to publicly update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law.
Last week, BioMar officially began trading on Nasdaq Copenhagen, marking a significant milestone in the company's history and welcoming more than…
The annual report for BioMar underlines the long-term positive development of the company. While volumes have increased, earnings were maintained at a…
Following a successful growth journey in collaboration with the joint venture partner Tongwei, the production facility in Wuxi will during 2026 be…
BioMar announces that it has acquired the remaining 30% shares in BioMar Ecuador. At the same time, BioMar Ecuador expects to expand the production…
BioMar Group has announced a partnership for the manufacture and distribution of aquafeed through Fóðurblandan’s production facility in Reykjavik,…
The first quarter of the year underlines the continuous strong performance of BioMar. Record high volumes for the quarter, combined with solid…
The year 2024 underlined the long-term positive development of BioMar. Profitability was remarkably strong in a year of declining volumes and revenue.…
BioMar's third quarter reveals a decline in sales volumes year-on-year, while the company is still heading for a strong full-year result. Although…